Primary Record
301836-41-9
- In stock
- 624 g
- Purity
- 99.2 %
- CAS
- 301836-41-9
Compound Identifiers & Properties
- CAS
- 301836-41-9
- PubChem CID
- 4521392
- SMILES
- C1OC2=C(O1)C=C(C=C2)C3=C(NC(=N3)C4=CC=C(C=C4)C(=O)N)C5=CC=CC=N5
- Canonical SMILES
- NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1
Names & Synonyms
- 301836-41-9
- SB-431542
- SB 431542
- SB431542
- 4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide
- 3tzm
- Compound 14
- Kinome_3428
- SB 431542 hydrate
- RefChem:1069917
- D0C7WP
- UNII-E1557V1V0N
- AC1ND2U2
- CHEMBL440084
- FHYUGAJXYORMHI-UHFFFAOYSA-N
- E1557V1V0N
- BSPBio_001064
- DTXSID7042693
- KBioGR_000404
- KBioSS_000404
- MLS006010130
- SCHEMBL155156
- SCHEMBL310028
- SB-431542 (Standard)
- MFCD05865244
- Bio2_000852
- C22H16N4O3
- GTPL8216
- orb1307603
- QCR-42
- TB1614-GMP
- DTXCID5022693
- SCHEMBL29353092
- SCHEMBL29359059
- SCHEMBL29381798
- SCHEMBL30033986
- BCBcMAP01_000166
- CHEBI:91108
- cid_4521392
- CTK8B8498
- KBio2_000404
- KBio2_002972
- KBio2_005540
- KBio3_000767
- KBio3_000768
- AOB6359
- EX-A144
- J1.722.247C
- MFCD11045982
- SB-431542 (GMP)
- sb432542
- TGF-beta RI Kinase Inhibitor VI
- BCPP000076
- BDBM476220
- Bio2_000372
- GLXC-05168
- HMS1362F05
- HMS1792F05
- HMS1990F05
- HMS3268G21
- HMS3403F05
- HMS3412L21
- HMS3648A08
- HMS3654O13
- HMS3676L21
- ZINC603769
- 4-[4-(1,3-BENZODIOXOL-5-YL)-5-(2-PYRIDINYL)-1H-IMIDAZOL-2-YL]BENZAMIDE
- BCP01765
- ABP000232
- AN-532
- ANW-60468
- BDBM50110208
- CC-103
- HB3555
- HY-10431G
- HY-10431R
- NSC756453
- NSC756649
- s1067
- AKOS016003159
- ACN-036843
- AM81241
- CCG-264802
- CID4521392
- CS-0135
- FB32804
- NSC-756453
- NSC-756649
- RL03059
- SB19480
- SDCCGGSK-0000195.P001
- SDCCGSBI-0639941.P003
- VZ27752
- CID:4521392
- IDI1_002127
- KS-000006B2
- SB-431542-A
- NCGC00025230-01
- NCGC00025230-02
- NCGC00025230-03
- NCGC00025230-04
- NCGC00025230-05
- NCGC00025230-06
- NCGC00025230-21
- 4CA-1141
- AC-23169
- AJ-23686
- AK-98838
- AS-16946
- BC660091
- HY-10431
- SC-71212
- SID:53790221
- SMR004701258
- SY016312
- ZB014564
- ZB014565
- US10865384, Compound SB431542
- AB0033746
- CB5360318
- RT-015651
- A8249
- B4003
- CS-0615624
- FT-0727008
- SB-431542?
- ST24042911
- SW212665-2
- X7468
- SB431542,SB-431542
- 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide
- A10826
- A25496
- S-7739
- W12958
- 4-[4-(2H-1,3-benzodioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl]benzamide
- AB01092258-01
- C459179
- SR-01000597591
- 4-(4-(1,3-Benzodioxole-5-yl)-5-(2-pyridyl)-1H-imidazole-2-yl)benzamide
- Benzamide, 4-(4-(1,3-benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl)-
- Q7388913
- SR-01000597591-1
- SR-01000597591-2
- BRD-K67298865-001-02-5
- BRD-K67298865-001-08-2
- BRD-K67298865-001-09-0
- 4-[4-(1,3-benzodioxol-5-yl)-5-(2-pyridyl)-1H-imidazol-2-yl]benzamide
- B0084-211014
- 4-(4-Benzo[1,3]dioxol-5-yl-5-pyridin-2-yl-1H-imidazol-2-yl)-benzamide
- 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide
- 4-(5-benzo[1,3]dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)-benzamide
- 4-[5-(1,3-Benzodioxol-5-Yl)-4-(Pyridin-2-Yl)-1h-Imidazol-2-Yl]benzamide
- 4-(4-(1,3-Benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl)benzamide
- 4-(4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl)benzamide
- 4-(4-Benzo[1,3]dioxol-5-yl-5-pyridin-2-yl-1H-imidazol-2-yl)benzamide
- 4-[4-(1,3-Benzodioxol-5-yl)-5-(2-pyridyl)imidazol-2-yl]benzamide
- 4-[4-(1,3-Benzodioxole-5-yl)-5-(2-pyridyl)-1H-imidazole-2-yl]benzamide
- 4-[4-(2-Pyridyl)-5-(1,3-benzodioxole-5-yl)-1H-imidazole-2-yl]benzamide
- 4-[4-(3,4-Methylenedioxyphenyl)-5-(2-pyridyl)-1H-imidazol-2-yl]benzamide
- SB 431542, 98%, a potent and selective inhibitor of ALK5 - 10MG 10mg
- 4-(4-Benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide
- 4-(5-(benzo[d][1,3]dioxol-5-yl)-4-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide
- 4-[4-(3,4-METHYLENEDIOXYPHENYL)-5-(2-PYRIDYL)-1H-IMIDAZOL-2-YL]-BENZAMIDE
- Benzamide,4-[4-(1,3-benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]-